CAPTRUST Financial Advisors’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
ACM
KGAMU
JCM
CAPTRUST Financial Advisors's CDLX Position: Q3 2022 in Review
CAPTRUST Financial Advisors sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 21 shares — an estimated $5K sold.
CAPTRUST Financial Advisors first reported a position in CDLX in Q2 2020 and held it in 9 quarters. The position peaked at $127K in Q4 2020. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.
- CAPTRUST Financial Advisors reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
- CAPTRUST Financial Advisors sold 21 Cardlytics shares in Q3 2022, an estimated $5K.
- CAPTRUST Financial Advisors first reported a position in Cardlytics in Q2 2020 and held it in 9 quarters.
- CAPTRUST Financial Advisors's Cardlytics position peaked at $127K in Q4 2020.
- 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.